IVISIONWORKS CO.,LTD. Logo

IVISIONWORKS CO.,LTD.

Accelerates social impact startups & develops digital therapeutics for cognitive rehabilitation.

469750 | KO

Overview

Corporate Details

ISIN(s):
KR7469750004
LEI:
Country:
South Korea
Address:
대전광역시 유성구 국제과학21로 54 -, 대전광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

IVISIONWORKS CO., LTD. operates with a dual focus on social impact investment and digital healthcare. Through its accelerator arm, Visionworks Ventures, the company discovers, nurtures, and invests in early-stage impact startups and social ventures aligned with the UN Sustainable Development Goals (SDGs). It provides comprehensive support programs, including mentorship, business development education, and access to seed investment and global acceleration opportunities. Concurrently, its Visionworks Neurons division develops digital therapeutics, focusing on neuroplasticity-based cognitive rehabilitation solutions for conditions such as Mild Cognitive Impairment (MCI) and emotional-cognitive digital treatments for Autism Spectrum Disorder (ASD).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-09-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 925.7 KB
2025-07-01 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.8 KB
2025-06-27 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Korean 12.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 996.8 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.7 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 18.5 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.3 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 80.6 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.9 KB
2025-03-07 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 10.2 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 12.0 KB
2025-02-20 00:00
Regulatory News Service
본점소재지변경
Korean 5.1 KB

Automate Your Workflow. Get a real-time feed of all IVISIONWORKS CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IVISIONWORKS CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IVISIONWORKS CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.